Navy bean and rice bran intake alters the plasma metabolome of children at risk for cardiovascular disease

KJ Li, EC Borresen, NN Jenkins-Puccetti… - Frontiers in …, 2018 - frontiersin.org
Abnormal cholesterol in childhood predicts cardiovascular disease (CVD) risk in adulthood.
Navy beans and rice bran have demonstrated efficacy in regulating blood lipids in adults …

Plant-based diets for children as a means of improving adult cardiometabolic health

MA Desmond, J Sobiecki, M Fewtrell… - Nutrition …, 2018 - academic.oup.com
Cardiovascular disease (CVD) is the largest contributor to global mortality, and this trend is
expected to continue. Although mortality rates have been falling, adverse developments in …

Use of coronary artery calcium testing to improve coronary heart disease risk assessment in a lung cancer screening population: the Multi-Ethnic Study of …

PK Garg, NW Jorgensen, RL McClelland… - Journal of …, 2018 - Elsevier
Background Assessment of coronary artery calcium (CAC) during lung cancer screening
chest computed tomography (CT) represents an opportunity to identify asymptomatic …

Heart Disease in Children.

RU Garcia, SB Peddy - Primary care, 2018 - europepmc.org
The pediatric cardiology field has developed rapidly over the past few decades. More
children than ever born with congenital heart disease (CHD) are growing into adulthood …

The optimal time of day for statin administration: a review of current evidence

K Awad, M Banach - Current Opinion in Lipidology, 2018 - journals.lww.com
The current limited evidence suggests that short-acting statins should be given in the
evening whereas long-acting statins could be given at any time of the day with allowing …

Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million …

S Mehta, R Jackson, R Pylypchuk… - International journal …, 2018 - academic.oup.com
Background Cardiovascular disease (CVD) risk prediction equations are primarily used in
clinical settings to inform individual risk management decisions. We sought to develop and …

The cost-effectiveness of PCSK9 inhibitors-The Australian healthcare perspective

R Kumar, A Tonkin, D Liew, E Zomer - International Journal of Cardiology, 2018 - Elsevier
Background For patients in whom statins are not tolerated or effective as monotherapy,
proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a new class of …

The prediction of therapy-benefit for individual cardiovascular disease prevention: rationale, implications, and implementation

NEM Jaspers, PM Ridker, JAN Dorresteijn… - Current opinion in …, 2018 - journals.lww.com
The prediction of therapy-benefit for individual cardiovascu... : Current Opinion in Lipidology
The prediction of therapy-benefit for individual cardiovascular disease prevention: rationale …

Longer-term lipid-lowering drug use and risk of incident and fatal prostate cancer in black and white men in the ARIC study

AM Mondul, CE Joshu, JR Barber, AE Prizment… - Cancer Prevention …, 2018 - AACR
Lipid-lowering medications, particularly statins, may protect against aggressive prostate
cancer. Fatal prostate cancer, the most clinically relevant outcome, remains understudied for …

A comparative analysis of current lipid treatment guidelines: nothing stands still

A Tibrewala, A Jivan, WJ Oetgen, NJ Stone - Journal of the American …, 2018 - jacc.org
Lipid treatment guidelines have continued to evolve as new evidence emerges. We sought
to review similarities and differences of 5 lipid treatment guidelines from the American …